Skip to main content
Clinical Trials/NCT06131762
NCT06131762
Recruiting
Not Applicable

Comparative Effects of Active and Positional Release Technique on Pain, Function and Temporospatial Gait Parameters in Runners With Plantar Fasciitis

Riphah International University1 site in 1 country26 target enrollmentFebruary 20, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gait
Sponsor
Riphah International University
Enrollment
26
Locations
1
Primary Endpoint
Gait parameters
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The study is randomized and single -blinded. Ethical approval is taken from ethical committee of Riphah International university Lahore.Participants who will meet criteria will be requested to give verbal consent and to sign written consent form. After signing consent form participants will be allocated to the group A and Group B by using computerized generated randomization. Group A will receive ultrasound then Active release technique while group B will receive ultrasound and Positional release technique for 4 weeks. Treatment sessions will be 12 sessions, 3 sessions per week on alternative days for 4 weeks

Detailed Description

A single blinded randomized clinical trial will be conducted on 26 subjects diagnosed for planter fasciitis from Jawad Club Faisalabad and Alfatah Sports Club, Faisalabad by looking for symptoms and tenderness at heel as mentioned in inclusion criteria and will confirmed by windlass test. Participants who will meet criteria will be requested to give verbal consent and to sign written consent form. After signing consent form participants will be allocated to the group A and Group B by using computerized generated randomization. Group A will receive ultrasound then Active release technique while group B will receive ultrasound and Positional release technique for 4 weeks. Treatment sessions will be 12 sessions, 3 sessions per week on alternative days for 4 weeks. Pain will be measured by Numerical Pain Rating Scale (NPRS), Foot and ankle disability will be assessed by Foot Function Index (FFI), while gait parameters i.e. walking speed will be measured by 4-meter walking test, and step and stride length will be evaluated by measuring tape by taking foot prints before and after the 4 weeks of treatment period. Data will be analyzed through statistical package for the social sciences (SPSS) version 22.

Registry
clinicaltrials.gov
Start Date
February 20, 2023
End Date
February 20, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male runners age between 18-30 years
  • Duration of running at least 6 months
  • Positive windlass test
  • Patients with unilateral or bilateral plantar fasciitis

Exclusion Criteria

  • Recent accidental foot or ankle injury
  • Previous lower-body surgical intervention within 6 months
  • Recent fractures in the lower limb (femur, tibia, fibula or foot bones) within 6 months
  • Diagnosed musculoskeletal disorders (rheumatoid arthritis, calcaneal spurs)
  • Diagnosed neuropathy, local and systemic neurologic disorders (including sciatica, tarsal tunnel syndrome, nerve entrapment of abductor digiti minimi and posterior tibial

Outcomes

Primary Outcomes

Gait parameters

Time Frame: pre and 4 weeks post intervention

gait parameters will be measured by 4-meter walking test

Foot Function

Time Frame: pre and 4 weeks post intervention

Foot function will be assessed by Foot Function Index (FFI),

Study Sites (1)

Loading locations...

Similar Trials